The event aims to deliver the latest knowledge on parrot nutrition and welfare and provide an opportunity to collaborate on education and potential next steps for research.
The full programme is as follows:
Sarah Hormozi, Head of Science & Education at PFMA said: “We are hoping to make it a worthwhile event, where parrot experts, welfare groups and parrot food industry can share their knowledge and experience.
"Through discussions we will come up with collective decisions and steps forward to improve the health and welfare of parrots that are kept in captivity, especially from a diet and nutrition perspective."
For ticket prices and to register: https://www.pfma.org.uk/pfma-parrot-symposium-2022
According to the Spring 2022 Voice of the Profession survey, one in four cats (24%) seen in practices are not having all of their welfare needs met.
The issues identified by vets as the most pressing at their practice were:
Ronnie (pictured right) will look at quality control and artefacts of sample quality and review the effects of different pathologies. By examining analyser output, he'll demonstrate how abnormalities of cells and plasma may affect measured parameters and their indices.
Using images, photomicrographs and video links, he'll move onto explain the techniques and equipment needed to complement analytical automation in order to confirm results quality.
Ronnie said: "“We now have more near patient testing in veterinary haematology than ever before. Quality is key to best practice and ultimately superior patient care. Sod’s Law states that ‘if something can go wrong, it will!’, so along the way to your generating a Complete Blood Count, it pays to be aware of some of the pitfalls that you may encounter.
“One should never underestimate the value of gross exam and simple methods that can be used to ensure sample quality and results accuracy. Seeing is believing after all!”
There will also be an open Q&A session with Ronnie after the presentation, so attendees are invited to bring any questions on all things haematology.
To register for the webinar, visit: https://register.gotowebinar.com/register/2458623866746094093
In the piece, which starts at 1:22:54 here, Gudrun explained that what is seen as “normal” and cute for these dogs, such as snorting and snuffling, is in reality a result of debilitating respiratory problems caused by the squashed faces that have made them so fashionable.
Today also highlighted the fact that flat-faced breeds have experienced a huge boom in popularity recently, driven by celebrity owners, advertising and the media. According to the Kennel Club, the French bulldog is set to knock the labrador off its perch as the UK's most popular breed.
Following the interview Gudrun said: "We shouldn’t be buying and breeding dogs on the way we want them to look - it should always be about prioritising welfare above appearance.
"These are breeds that can suffer just by walking around or eating, which is why we’re calling on the media and advertisers to stop using them in their adverts.
"It is also difficult to turn on the TV, check Instagram or see a celebrity photo without also seeing a brachycephalic breed so it’s not surprising that demand for these dogs is rising."
Gudrun urged anyone thinking about buying a brachycephalic breed to talk to their local vet and think about choosing a healthier breed or crossbreed instead.
The challenge is part of Merial’s #CALFMATTERS calf pneumonia vaccination awareness campaign.
In total, the group aims to walk over 70,500 miles and raise £15,000 for Farm Africa, a charity which helps farmers and communities in developing countries by giving the advice and products they need to lift themselves out of poverty.
So far the challengers have covered one fifth of their total target, and completed the equivalent of several iconic distances including the Appalachian Trail, Lands End to John O’Groats, and ‘virtually’ crossed entire countries including Australia, China and Japan.
The participants have committed to the challenge by upping their physical activity. Merial has provided them with Fitbit fitness trackers to record their daily steps, which count towards the virtual teams’ total progress. The goal is 141 million steps in 20 weeks.
Robert Smith MRCVS from Farm First Vets is one of the highest steppers of the group. He recently scaled Ysgyryd Fawr (The Big Skirrid), one of the Black Mountains in Wales’ Brecon Beacons, for the challenge. He said: "I used to think of myself as a coiled spring ready for action, but the steps challenge has forced me to realise there is plenty of scope to increase my activity levels significantly. Hopefully when it is all over I will see the benefits and feel physically fitter for it."
Robert has taken the challenge one step further by encouraging his wife, two daughters, and Farm First Vets practice staff to join him in the challenge, with an added incentive. Between now and the BCVA Congress on 19th October, Farm First Vets will donate £50 to Farm Africa for every member of Robert’s team who completes the #CALFMATTERS challenge. Additionally, for every member of staff that achieves an average of 10,000 or more steps per day, the practice will donate £50 to XL Vets’ and BCVA 50th Anniversary charity, Send a Cow.
If you want to support those taking part in the challenge, you can do so at: www.justgiving.com/fundraising/calfmatters.
The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
The survey was held between the 1st and 5th May and was sent to the 3,139 UK veterinary practices for which the RCVS holds a unique email address. In total it gathered 251 responses (a response rate of 8%) compared to the 532 responses to the initial survey conducted between 3rd and 7th April (a response rate of 17%).
The main changes compared to last month's survey were:
Lizzie Lockett, RCVS CEO, said: "This latest survey has identified some positive trends in terms of a slight uptick in business, including turnover, and fewer incidences of staff having to take time off with COVID or COVID-like symptoms.
“I am glad to see that the framework we published in April has, so far as we can see, provided veterinary professionals with greater guidance and reassurance regarding the fact that if it is feasible to do something safely under social distancing guidelines, then they can go ahead, if they choose to.
"We left plenty of scope for veterinary professionals to use their clinical judgement as to what services actually offer, depending on their facilities, level of staffing, availability of protective equipment, local disease pressures and so on.
"However, it is also clear that we are, by no means, out of the woods and that veterinary businesses are still struggling financially, with some of them reporting a very acute impact of the coronavirus and the associated restrictions on their businesses.
“We will continue to monitor the situation via these regular surveys, with the next one planned for early June. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected. This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
Avid has released a new version of it's microchip registration system, which offers a significantly enhanced statistical analysis of the microchipping done at your practice.
The new MicroChip Plus section of the site is specifically for implanters, and contains the following:
Avid says the registration system, which has built-in postcode software, can now re-use more registration details, so that registering a complete litter will take less time. This is especially important when microchips are being registered for or by breeders.
Denise Chaloner, Manager at Avid said: “Avid MicroChip Plus gives our customers more control of how they manage pet microchipping within their organisation. Listening to feedback has inspired Avid to develop a more tailor-made and efficient system for the end user, also enabling the generation of reports, statistics and targets”.
Customers with supporting practice management systems may register microchips directly from their software using VetXML and VetEnvoy.
For more information contact Avid on freephone 0800 652 7 977 or email sales@avidplc.com
The Veterinary Medicines Directorate (VMD) has granted MSD Animal Health a provisional UK marketing authorisation for Bovilis SBV, the first vaccine specifically targeting the Schmallenberg virus (SBV) in cattle and sheep.
SBV, which emerged in late 2011, is transmitted via insect vectors, mainly midges and causes transient clinical symptoms in adult cattle and sheep, such as fever, diarrhoea and reduced milk yield, as well as congenital malformation in newborn calves and lambs. As of March 31st 2013, 1753 cases of SBV had been confirmed throughout the UK. SBV has now been detected in every county in England and Wales.
Andras Bolcskei, Country Manager, MSD Animal Health UK said: "On behalf of Merck MSD, we would like to thank the VMD for its partnership and support to fast track the availability of Bovilis SBV to the market. There was a tremendous urgency for a SBV vaccine in the UK especially given the marked increase in confirmed cases over the past year and the increasing importance to help control this devastating disease."
MSD says that studies it conducted in support of the provisional marketing authorisation showed that all animals responded with formation of virus neutralizing antibodies. During the studies, reduced viraemia against SBV was observed in sheep vaccinated once and prevention of viraemia was observed in cattle vaccinated twice, whereas all animals in the control groups developed infection and became viraemic. In studies to date, Bovilis SBV has been shown to be efficacious in cattle and sheep.
The vaccine is based on wild-type SBV that has been inactivated and contains an adjuvant that stimulates the immune response.
The vaccine will be available in 20ml and 100ml vials. Bovilis SBV is indicated for the active immunisation of cattle to prevent viraemia against SBV and for the active immunisation of sheep to reduce viraemia against SBV.
MSD says it is working diligently to expedite stocks to the UK, and expects Bovilis SBV to arrive in the UK in the coming weeks.
Elanco Companion Animal Health, maker of Comfortis and Trifexis, has launched Common parasites of dogs, a new publication designed to help veterinary professionals advising clients about the benefits of regular parasite control.
Focusing on endoparasites, the booklet includes information about roundworm (Toxocara canis and Toxascaris leonine), hookworm (Ancylostoma caninum), whipworm (Trichuris vulpis), heartworm (Dirofilaria immitis), lungworm (Angiostrongylus vasorum), tapeworm (Dipylidium caninum) and fleas (Ctenocephalides spp.). It includes details on the lifecycle of the parasites, how they develop, symptoms and sources of infection, whether the parasites are a risk to pets and humans and illustrations to explain their lifecycle and show what each of the parasites looks like.
Common parasites of dogs is available in two formats: a 'tablet friendly' electronic version and a booklet consisting of individual cards on a metal snap ring.
Matthew Rowe, senior brand manager at Elanco Companion Animal Health, said: "Pet owners often get confused by the different parasites that can be picked up by their dogs. The new common parasites of dogs education tool will help veterinary professionals advise their clients about parasites and the benefits of routine worming and flea treatments."
For a copy of Common parasites of dogs electronically or as a booklet, contact your Elanco Companion Animal Health key account manager or email elancoCAH.uk@elanco.com.
Virbac is running a special promotion through which UK-based practitioners who order from the company's reproductive product range can claim a free copy of the evidence-based book Clinical Canine and Feline Reproduction by Margaret V. Root Kustritz.
The book covers 100 separate questions across a range of reproductive issues, and currently retails for £47.99.
Virbac product manager Chris Geddes MRCVS said: "We offered this book as part of a promotion in 2010 and it proved extremely popular. As a result we thought we would give vets another chance to get a free copy."
As the Assistant Dean at the Minnesota College of Veterinary Medicine, Margaret V. Root Kustritz is a leading figure in feline and canine reproduction and one of the world's most renowned experts in reproduction. Mr Geddes said: "The book is based on the questions veterinary surgeons have asked her over the years, and so is a valuable reference tool for any vet."
Numbers are limited, and the book is available on on a 'first come first served' basis. Anyone interested should either contact their territory manager or call Virbac on 01359 243243.
BCF has announced upgrades to the Easi-Scan bovine ultrasound scanner which include improved image quality and additions to the BCF Universal Googles (BUGs) range.
The BUGs range now includes a new LCD model and a monocular version. According to the company, the LCD version provides a softer, more familiar image and considerably lower price, while the monocular version is ideal for the small percentage of people that struggle to see a single image in a binocular style goggle.
John Dawson from Willows Veterinary Group, Cheshire said: "The LCD BUG has a softer image which I prefer. They give more differentiation of echogenic grading allowing more detail to be seen. When I first used them I thought they were going to be more expensive, but to get a better image at a lower price I was astonished."
Gavin Mitchell from BCF said: "These new product developments for Easi-Scan and BUGs are a great illustration of how we are committed to responding to our customers' feedback, opinions and recommendations. At BCF, we design, develop and manufacture our own equipment. It is so important to continually work closely with our customers, to continue to create world-leading ultrasound equipment."
For more information visit www.bcftechnology.com
The Government has been forced to scrap plans for compulsory dog insurance less than a two weeks since they were revealed in leaked Defra documents.
Environment Secretary Hilary Benn has now ruled out the idea.
Apparently, the climbdown followed protests that compulsory insurance was no more than a 'dog tax' which would do nothing to curb the problem of dangerous dogs.
There's a certain irony in the way the story was reported in The Sun newspaper, with the headline: 'Labour forced to ditch pet plan'.
Indeed!
The article argues that as the equine influenza (EI) vaccine supply returns to normal, there is sound scientific evidence why bi-annual vaccination schedules should be re-implemented promptly.
Whilst the scale and number of outbreaks has been relatively small since the introduction of mandatory EI vaccination by most competitive equestrian disciplines in the 1980s, disease events such as those experienced in the UK in 1989, 2003 and most recently in 2019 have demonstrated EI’s epidemic potential, even in vaccinated horse populations.
In their article 'Equine influenza bi-annual boosters: what does the evidence tell us?' Victoria Colgate and Richard Newton discuss what has been learnt from previous outbreaks and explain the evidence from mathematical models to show why bi-annual boosters are beneficial.
The authors say that epidemiological data from previous natural EI outbreaks have repeatedly demonstrated the impermanent nature of the protection provided by vaccination and observational field studies have repeatedly highlighted the potential for 12-monthly boosters to leave a vulnerable immunity gap at both the individual animal and population level.
Mathematical models of EI transmission confirm that six-monthly rather than annual EI booster vaccinations are preferable to establish and maintain effective population level immunity to EI.
Ideally vaccine strains should be updated in a timely manner to ensure inclusion of the most epidemiologically-relevant strains, however, this is a slow and expensive process for equine vaccine manufacturers.
In the absence of updated vaccine strains, bi-annual vaccination is strongly recommended to help compensate for antigenic drift between vaccine and circulating EI viral strains
Professor Celia Marr, Editor of the EVJ said: “Although the recent EI vaccine shortage has necessitated a temporary relaxation of competition vaccine schedules, we must now renew the message that six-monthly boosters are optimal and necessary.”
The Editorial can be found at https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13898 and is free to view.
Two related articles can be found here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13874 and here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13885
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
The broached bottle must be kept refrigerated between 20C and 80C until the next use.
Virbac says that whilst this may not seem a huge change, it significantly increases the cost-effectiveness and convenience to farmers.
The SPC changes mean that
Bovigen Scour is available in 5 and 30 dose bottles.
The information has been made available amid concerns from behaviourists and animal welfare organisations that there may be a rise in behavioural issues as lifestyle restrictions are lifted.
The Q&A explains what some of the behavioural concerns are and how they can be prevented and managed. Topics include separation-related issues, animals becoming anxious as the world around them becomes busier and noisier, and puppies lacking appropriate skills when greeting animals (including dogs and people) from other households.
The Q&A can be downloaded here.
Dr Hannah Donovan, vet, clinical animal behaviourist and Social Media Officer at the BVBA said: “We hope that this information will help vets to support their clients and their pets when faced with potential challenges as we transition out of lockdown.”
Professor Ian Ramsey, President of the BSAVA added: “This guidance has been developed in collaboration with the BVBA with the intention of supporting vets in practice in an ever-changing environment. It sits alongside other practical BSAVA resources vets can share with pet owners, such as Vaccination Guidance and Neutering Guidance, and follows the BSAVA’s core ethos – ‘By the profession for the profession.”
The BSAVA has also created a collection of resources for veterinary professionals relating to the prevention, management and treatment of behavioural issues in cats of dogs, which is freely available in the BSAVA Library until the end of July.
The collection includes chapters from the BSAVA Manual of Canine and Feline Behavioural Medicine; for those wishing to buy the full manual, there is a £10 discount on both the print and online editions throughout July (using code BEHAV10 on checkout).
Further information for vets can be found in the BSAVA’s COVID-19 resources here.
Hosted by Nick Steele, National Consulting Manager at Zoetis and Rachael Whittle, a business coach specialist, the course will present the best techniques to analyse mixed personalities that cause problematic situations, allowing staff to deal with difficulties that may occur on a daily basis. Nick will use his knowledge from working at the world’s largest global animal health company, while Rachael will use her experience in business training and coaching to help anyone that works with people on a daily basis manage these daily challenges, using common examples from their own background.
For the chance to win a free place at this event, send an email with your name, the name of your veterinary practice and the reason attending this course will help grow your practice’s business to royalcaninvet.gbr@royalcanin.com.
Royal Canin will select three applicants at random, and will inform the winners via email, by Thursday 30 June.
Places on the course can also be booked by calling 01453 872731 or by visiting www.spvs-vpma-events.co.uk. Workshops cost £265 plus VAT for non-members and £190 plus VAT for VPMA and SPVS members (group/ bulk booking discounts are also available). Cost includes CPD certificates, lunch and refreshments.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
Procanicare contains three canine-specific strains of Lactobacillus bacteria, which the company says are proven to improve stool consistency, accelerate recovery following acute episodes of diarrhoea and improve well-being.1
The company also points to a number of studies which it says are evidence of the importance of supporting puppies' intestinal microbiomes.
'New puppy diarrhoea' is, it says, typically due to exposure to factors that are known to risk microbiome disturbance, such as diet change and going to a new home, at a time when the microbial population is at its more sensitive.2
Animalcare says other studies show that microbiome disturbances in early life can have a significant impact on health in adulthood.2,3
James Beaumont, Marketing Manager at Animalcare said: “We often hear from breeders, new puppy owners and vets that puppies which have had Procanicare seem brighter, have firmer stools and less flatulence. With the evidence mounting that the adult intestinal microbiome is shaped in early life and knowing the important and varied role that it has in wider health throughout life, we want to help vets proactively support the GI health of their youngest patients by providing Procanicare for them to trial, with no risk.”
References
Dechra Veterinary Products has launched Vitamin K1 tablets for dogs, which help reverse the effects of exposure to anticoagulant rodenticides.
The launch of the NFA-VPS licensed 50mg tablets means that veterinary professionals can have a ready supply of Vitamin K when treating animals which have been exposed or may have been exposed to serious poisoning. Previously, the tablets where only available as a special import certificate product following Dechra's acquisition of Eurovet.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Vitamin K1 is an absolutely key therapy in the treatment of potential and accidental exposures to anticoagulant poisoning in animals, mainly in pet dogs. It helps to assist with blood clotting, and the treatment protocol advises continued oral therapy following an initial injectable preparation of Vitamin K.
"The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding suspected or confirmed poisoning of all types of animals, whether accidental or deliberate exposure.
"We had been able to offer the Vitamin K1 injection and tablets via a SIC, when previously sometimes only preparations for human use were available. Therefore, we are delighted to now launch a licensed tablet which will ensure a ready supply and speed of therapy for animals affected by anticoagulant rodenticides."
Carol added: "Anticoagulant poisoning queries are already the second most common type received by the Veterinary Poisons Information Service, and with the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."
Vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following parenteral treatment, are available in boxes of 14 tablets, in blister packs of seven tablets.
For more information, please visit www.dechra.co.uk
The Goddard Growlers are putting the final touches to their training ahead of the Vet Charity Challenge event which takes place at Pershore College in Worcestershire on 28 September.
The team comprises Stone Lion Head Vet Roger Bralow; Practice Manager for North West London, Adrian Hayter; Philippa Davis, Regional Manager for NE London and Lisa Cooper, VN and Hospital Manager for Wanstead Hospital.
Philippa Davis said: "Our training regime is going well despite the injuries we've sustained making us consider that we might be 'too old' for this malarkey. I've certainly had to stop saying 'I don't do' running as I've found that I'm enjoying it and will continue to do it after the challenge. We make a great team and while the events will be very tough, we'll have some laughs along the way.
We certainly have a will to win and our fellow teams will find us highly competitive and growling at them at every opportunity! Seriously though, we're all really looking forward to it and watching the long range weather forecast with unusual interest! We're also delighted to be helping the fantastic causes which the Vet Charity Challenge is fundraising for this year. Our colleagues across the Goddard Group are giving us great support and we have already raised more than £600. Bring it on!"
The Growlers' progress can be followed by 'liking' their facebook page, 'Goddard Growlers', which also provides links for anyone wanting to support them with sponsorship. Alternatively, donations can be made at http://uk.virginmoneygiving.com/team/goddardgrowlers
William McEwan BSc MRes PhD, now working at the MRC-Laboratory of Molecular Biology in Cambridge, has been awarded the ABCD and Merial Young Scientist of the Year Award 2010 for his work on the replication and cross-species transmission of feline immunodeficiency virus infection in domestic cats and lions, and the restriction factors in these species in particular.
Dr McEwan said: "Understanding the means by which host species are able to prevent viral replication gives us insight to the mechanisms of infection and may allow us to engineer therapy based on similar mechanisms or by enhancing immune responses."
The award was presented by Professor Marian C. Horzinek, Chair of the European Advisory Board on Cat Diseases (ABCD) and of the award jury. He said: "William McEwan presented a very original, high quality paper. His research has indicated the ability of hosts to potently restrict retroviral replication - given sufficient evolutionary time. It has also highlighted felids as a taxon that is potentially highly prone to cross-species transmission of immunodeficiency viruses".
The ABCD and Merial Young Scientist Award, created in 2008 and worth 1000 €, is funded by Merial and is presented to a young scientist in veterinary or biomedical science, who has made an original contribution in the field of feline infectious diseases and/or immunology. Applicants should have published their findings in a journal listed in PubMed or Web of Science or have had them accepted by another recognised assessing body.
Candidates should be based in Europe, have completed a veterinary or biomedical curriculum, and be under 35 years of age at the time of application. Applications for the 2011 award are now being invited (deadline 15 January 2011). For more information, visit: www.abcd-vets.org
I'm delighted to welcome Celia Marr from Rossdales and Edd Knowles from Bell Equine, who have kindly agreed to be our contributing experts. They'll drop in from time to time to add anything helpful they can to the forum discussions.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
All members of the site with an interest in equine medicine are now invited to press the join button on the left hand side of the group home page (when viewed on tablet or bigger). You may also wish to select the option to receive a daily or weekly digest of new content by email, which you can cancel at any time.
Equine is the third special interest group launched on VetSurgeon.org. The other two are Small Animal Medicine and Small Animal Dentistry.